Images
Participants
Contact
"Saber Vivir" magazine dedicates an article to a study—co-led by Cristina Fillat, head of the Gene Therapy and Cancer Group at IDIBAPS, and Raúl Méndez, ICREA researcher at IRB Barcelona—on an innovative approach to provide an adenovirus with high specificity against tumour cells.
The article includes Raúl Méndez's comments about the effectiveness of this new strategy to achieve genetically modified viruses that infect only tumor cells, thus preserving healthy tissues: "It would be effective in a large number of tumours".
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
